ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 51 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,358,000 | -12.5% | 433,585 | 0.0% | 0.46% | -9.2% |
| Q2 2021 | $11,833,000 | -45.1% | 433,585 | -41.8% | 0.51% | -32.4% |
| Q1 2021 | $21,535,000 | -11.7% | 744,370 | -14.2% | 0.76% | -30.5% |
| Q4 2020 | $24,393,000 | -25.2% | 867,170 | -22.1% | 1.09% | -42.2% |
| Q3 2020 | $32,619,000 | -16.3% | 1,113,265 | -13.7% | 1.88% | -32.6% |
| Q2 2020 | $38,990,000 | -22.4% | 1,289,360 | -23.5% | 2.80% | -38.6% |
| Q1 2020 | $50,259,000 | – | 1,686,527 | – | 4.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $128,526,634 | 7.99% |
| Saturn V Capital Management LP | 487,179 | $8,787,113 | 7.29% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $44,400 | 4.96% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $8,421,807 | 3.66% |
| Logos Global Management LP | 1,400,000 | $20,720,000 | 2.43% |
| Rubric Capital Management LP | 2,742,519 | $40,589,281 | 1.77% |
| 1492 Capital Management LLC | 174,546 | $2,583,281 | 1.67% |
| AlphaCentric Advisors LLC | 78,500 | $1,161,800 | 1.15% |
| MPM BioImpact LLC | 262,069 | $3,878,621 | 1.01% |
| Orbimed Advisors | 2,460,108 | $36,409,598 | 0.70% |